Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Mol Genet Metab. 2014 Jul 21;113(0):92–99. doi: 10.1016/j.ymgme.2014.07.008

Figure 4.

Figure 4

HS levels in serum of seven patients with MPS II who underwent ERT for more than two years. a) ΔDiHS-0S; b) ΔDiHS-NS. Each line describes an individual patient. *: shows significant difference between pre-treatment and post-treatment.